The National Lung Cancer Forum for Nurses is currently in the process of applying for charitable incorporated status (CIO). The benefits of becoming a CIO means that the Forum will receive greater legal protection to safe-guard the organisation and the trustees as well as the commercial advantages of having a more business structured environment (e.g. able to enter into legal agreements with sponsors, suppliers). Members and trustees of the NLCFN will be personally safeguarded from any financial liability the charity may incur, which is not the case for unincorporated organisations such as ours.
If you are interested in becoming a trustee please see HERE for more information.
Diana Borthwick is a Clinical Nurse Specialist in Lung Cancer at the Edinburgh Cancer Centre and was appointed in 1999 following a long clinical career in cancer and general nursing. She developed her interest in working with patients with lung cancer whilst she worked in clinical trials looking after patients with lung and neurological cancers.
Diana has an established reputation as a leader in the lung cancer nursing field and was one of the founding members of the Scottish Lung Cancer Forum. She is the current chair of the National Lung Cancer Forum for Nurses. She is also a committee member of the International Thoracic Oncology Nursing Forum and a member of the Global Lung Cancer Coalition.
Diana leads and collaborates on a number of research projects in the areas of patient experience, symptom management in cancer care, lifestyle & rehabilitation and role of the lung cancer nurse specialist. She has a particular interest in how patients and carers live with and beyond a diagnosis of cancer and the impact of that diagnosis on the whole family. She has published and is regularly invited to international and national conferences to present.
Her hobbies include hiking and rock climbing and can be often found at the end of a rope on a mountain in France.
Lorraine Creech (Chair)
Lorraine completed her nurse training in Manchester and went on to hold posts in general medicine, community and hospice care. She became a Macmillan Palliative Care Nurse at East Cheshire NHS Trust in 1990 and developed the Macmillan Lung Cancer Nursing Service in 1999. In 2007 she was appointed as the Macmillan Lung Cancer Lead Clinician and she also held the post of Non Medical Prescribing Lead. Lorraine has a Masters in Medical Ethics of Cancer and Palliative Care and MSc level qualifications in clinical examination and diagnostics. She was the first nurse non medical prescriber at the Trust. She has also undertaken the National Cancer Leadership Programme.
Lorraine was the first nurse member of the British Thoracic Society Lung Cancer Working Party and has been a committee member of the National Lung Cancer Forum for Nurses. She also worked with the Department of Health on the Lung Cancer Awareness, Action and Advisory Group. In 2014 she became the Mesothelioma Clinical Nurse Specialist for Greater Manchester and Cheshire.. She is the clinical nurse representative on the Manchester Lung Cancer Pathway Board and a Macmillan Alumni Ambassador.
After spending ten years in biomedical science and biomedical engineering within the NHS Alison Leary undertook a nursing diploma at The Nightingale School at St Thomas Hospital (now Kings College London). She attained a Masters in biomedical science (Haematology) before specialising in lung cancer and thoracic surgery. Alison obtained PhD in medicine from University College London in thoracic oncology and she continues to research in this area and also undertakes various projects around the modelling of complex systems. Alison is currently a Professor of Healthcare & Workforce Modelling at London South Bank University. Her interests are in the complexity of healthcare, math models and data science..
Dr Michael D Peak MB, ChB, FRCP
Dr Peake’s main current role is as the Clinical Lead for Public Health England’s National Cancer Intelligence Network where he oversees the clinical understanding and analysis of UK-wide population data on cancer. He is an Honorary Consultant and Senior Lecturer in Respiratory Medicine for the University Hospitals of Leicester and has had a major interest in lung cancer and mesothelioma for many years. He is co-clinical Lead for the National Lung Cancer Audit in the Royal College of Physicians, where he is Associate Director of the Clinical Effectiveness and Evaluation Unit. He was National Clinical Lead for Ling Cancer and for NHS Cancer Improvement until the dissolution of the organisation in the NHS reforms. Amongst other roles he is a member of the steering group of the British Thoracic Oncology Group, chair of Mesothelioma UK and a member of the National Advisory Group for Clinical Audit and Enquiries. He has been involved in the development and implement-ation of national cancer policy since the late 1990s. He has published widely with his major interests being in early diagnosis and improving outcomes for cancer patients by proper service configuration, supported by good clinical outcome data.
John White completed his term of office as the Chair of the National Lung Cancer Forum for Nurses in January 2014. He has been a keen and active supporter of the NLCFN since he became a Lung Cancer Nurse Specialist in 2002 and has thoroughly enjoyed the professionalism and camaraderie of all those that he has met in this time. John is the Lead Lung Cancer Nurse Specialist at the Leeds Teaching Hospitals NHS Trust. He sits on the Lung Cancer Clinical Reference Group and is the Vice-Chair of the West Yorkshire Lung Cancer Group.